Evidence map›Paper›PMID 42198463›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Assessing the Safety of Carbon Dioxide Extracts of

Galiya Ibadullayeva, Maigul Kizatova, Karlygash Raganina, Meruyert Tleubayeva, Aliya Mamatova, Rauan Botabayeva, Aigerim Karaubaeva, Aktolkyn Ibadullayeva, Aruzhan Darbassova, Lashyn Kiyekbayeva and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Galiya IbadullayevaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Maigul KizatovaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Karlygash RaganinaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.ORCID 0000-0002-4022-9497
Meruyert TleubayevaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Aliya MamatovaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Rauan BotabayevaDepartment of Pharmaceutical Technology, South Kazakhstan Medical Academy, Shymkent 160001, Kazakhstan.
Aigerim KaraubaevaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Aktolkyn IbadullayevaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Aruzhan DarbassovaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.
Lashyn KiyekbayevaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.ORCID 0000-0001-9827-0129
Rizvangul AyupovaDepartment of Pharmaceutical Technology, Kazakh National Medical University Named After S.D. Asfendiyarova, Almaty 050000, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acorus calamusacute toxicityantitussive activityCalendula officinalischronic toxicityCO2 extractionsafety assessment

Identifiers

PMID42198463
PMCPMC13209801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.